Pegzilarginase-nbln
Generic Name: pegzilarginase-nbln
Manufactured by IMMEDICA PHARMA AB. Dosage form: Injectable. Route: Injection. Active ingredients: PEGZILARGINASE-NBLN (0.1MG/KG). Application: BLA761211.
Overview
Manufactured by IMMEDICA PHARMA AB. Dosage form: Injectable. Route: Injection. Active ingredients: PEGZILARGINASE-NBLN (0.1MG/KG). Application: BLA761211.
Dosage
Available as injectable for injection use.
Related Medications
Anemone Hepatica Var Obtusa
anemone hepatica var obtusa
Sore throat pain*
Sutimlimab-jome
sutimlimab-jome
Classical Complement Pathway Inhibitor [EPC]
11 DESCRIPTION Sutimlimab-jome, a classical complement inhibitor, is a humanized monoclonal antibody expressed by recombinant in Chinese hamster ovary (CHO) cells and produced in vitro using standard mammalian cell culture methods. Sutimlimab-jome is composed of two heterodimers. Each heterodimer is composed of a heavy and a light polypeptide chain. Each heavy chain (H-chain) is composed of 445 amino acids and each light chain (L-chain) contains 216 amino acids.
Cocklebur Xanthium Strumarium
cocklebur xanthium strumarium
Dosage form: INJECTION, SOLUTION. Route: PERCUTANEOUS, SUBCUTANEOUS. Active ingredients: XANTHIUM STRUMARIUM POLLEN (.05 g/mL). Category: BLA.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.